Replies to post #120803 on Biotech Values

[biomaven0]

either the RXII vaccine itself or the comparator vaccine (referred to as "X")

These are two vaccines they are testing in the same trial.

There could actually be something here - it's hard to tell. One problem from an investment perspective is that their Phase III will take a long time - I'd guess two or three years after full enrollment.

Peter

[jaybird249]

Maybe, but 10 different sub groups in the Phase 2 24 month data all had remarkable results.

Fluke?

I think not. Even if it were questionable, it will still be a great momentum play.